A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
Part of paid clinical trials in San Francisco, California.
- Sponsor
- MiNK Therapeutics
- Study ID
- NCT07615010
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Pneumonia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- agenT-797 — DRUGIntravenous infusion
- Placebo — DRUGIntravenous infusion
- Standard of Care (SOC) — DRUGAntimicrobial therapy and corticosteroids per applicable guidelines.
Study Details
This clinical trial will evaluate the efficacy and safety of a single intravenous dose of agenT-797 administered in addition to standard of care (SOC), compared with placebo plus SOC, in reducing short-term mortality in adult participants with severe pneumonia and moderate to severe AHRF. All participants will receive SOC management for severe pneumonia and acute respiratory distress syndrome (ARDS).
Key Dates
- Start date
- May 22, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: agenT-797 plus SOCParticipants will receive agenT-797 and SOC.
- Placebo Comparator: Placebo plus SOCParticipants will receive placebo and SOC.
Primary Outcome Measure
Number of Deaths (All-cause Mortality) [ Time Frame: Day 1 through Day 28 ]
Central Contacts
- MiNK Therapeutics Clinical Trial Information1-212-994-8250
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCSF Medical Center at Parnassus Heights | San Francisco | California | 94143 | Michael Matthay, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Memorial Hermann Hospital | Houston | Texas | 77030 | Charles Cox, MD (PRINCIPAL_INVESTIGATOR) |
| University Hospital | San Antonio | Texas | 78229 | Donald Jenkins, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary ImpairmentRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.PHASE2 · Recruiting · Vasomune Therapeutics, Inc. · Newport Beach, California
- A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world SettingRecruiting · Pfizer · El Centro, California